The Globe and Mail is reporting that Middleton Family Medicine in Toronto has been forced to halt sales of the popular allergy medicine Ambien after it was found to contain a synthetic chemical.
The medication was initially made in Germany, but it has now been distributed in Canada under the brand name Anafranil.
Anaframol is a synthetic drug that has a very similar chemical structure to Ambien, and was previously used in the manufacture of a variety of other prescription medications, including the common pain reliever ibuprofen and the painkiller oxycodone.
The drug was originally approved for use by the U.S. Food and Drug Administration to treat moderate to severe pain but it is no longer approved for any other conditions, including those that can cause seizures.
The Globe reported that the drug’s generic counterpart was also approved for the treatment of moderate to moderate pain but the manufacturer, AstraZeneca, stopped selling the product last year.
According to the Globe, the company has since rebranded the medication to Anafral.
The company’s statement on its website said that its intent was to ensure consumers are aware of the potential risks of the drug, and that they can access it on prescription at a safe, convenient and cost-effective price.
A spokesperson for the family medicine said in a statement that it was in discussions with health authorities and that the family doctor has informed its patients that Anafra has not been approved for their specific needs.
However, the Globe reported the family was not informed that Anabranil had been removed from the market, or that it had been withdrawn from the U